Chemotherapy-induced Anemia

• CLINICAL_TRIALS trial_result · 2009-02-02
  Clinical Trial Update: A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy [Phase 3]

  A Phase 3 trial evaluating recombinant human erythropoietin for chemotherapy-induced anemia in cancer patients has completed.

• FDA approval · 2008-03-07
  FDA Approved: PROCRIT — Supplemental Application (Janssen Products, LP)

  FDA approved a supplemental application for PROCRIT (epoetin alfa) submitted by Janssen Products, LP.

• FDA approval · 2007-12-17
  FDA Approved: ARANESP — Supplemental Application (Amgen, Inc)

  FDA approved Amgen's supplemental application for ARANESP (darbepoetin alfa), resulting in an updated approval status for the product throug…

• FDA approval · 2007-11-08
  FDA Approved: ARANESP — Supplemental Application (Amgen, Inc)

  FDA approved a supplemental application for ARANESP (darbepoetin alfa) from Amgen, Inc.

• FDA approval · 2007-03-09
  FDA Approved: ARANESP — Supplemental Application (Amgen, Inc)

  FDA approved a supplemental application for ARANESP (darbepoetin alfa) from Amgen, Inc.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.